STEPHANIE PORTER: Open Payments
NPI 1396238929 · THOUSAND OAKS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 63 payments from 17 companies in 2025. Trend: 2023 $1,807 · 2024 $1,965 · 2025 $1,509
Food & beverage: $1,509
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 15 | $249 |
| UCB, Inc. | 7 | $193 |
| Galderma Laboratories, L.P. | 4 | $181 |
| ABBVIE INC. | 11 | $150 |
| Regeneron Healthcare Solutions, Inc. | 2 | $134 |
| PFIZER INC. | 4 | $102 |
| LEO Pharma Inc. | 4 | $95 |
| Lilly USA, LLC | 3 | $77 |
| GENZYME CORPORATION | 2 | $72 |
| Arcutis Biotherapeutics, Inc. | 3 | $58 |
Products named: OPZELURA, DUPIXENT, Bimzelx, NEMLUVIO, SKYRIZI, CIBINQO, ANZUPGO, Zoryve.
Industry payments across CA — which companies pay providers there.
